Skip to content

1. Current Status, Position

Mr Gustaf Befrits is a health economist with the Stockholm County Council. 

2. Education

Gustaf Befrits has a Master’s degree in Health Economics from the Karolinska Institute in Stockholm.

3. Research Area

Gustaf Befrits has several years of experience from the pharmaceutical and medical technology industry. In 2009 he joined the TLV, the Swedish National Reimbursement Authority as a health economist. He has also served as an expert in the EU commission project regarding uptake of biosimilars under the wider project “Platform on Access to Medicines in Europe”. Gustaf Befrits has worked extensively reevaluating the TNF-alfa inhibitors at both national and regional levels. Since 2013 he works for the Stockholm County Council which is the organisation responsible for supplying health care to the Stockholm region of approximately 2 million inhabitants. In this capacity, he has coordinated the introduction of biosimilar TNF-alfa inhibitors in Stockholm.

4. Conflict of interest: none

 


×

Deadline extended to July 15th

Problems caused by shortages are serious, threaten patient care and require urgent action.

Help us provide an overview of the scale of the problem, as well as insights into the impact on overall patient care.

Our aim is to investigate the causes of medicine and medical device shortages in the hospital setting,  while also gathering effective solutions and best practices implemented at local, regional, and national levels.

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.